Published in Clin Exp Allergy on May 01, 2000
Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med (2005) 2.32
Occupational asthma: etiologies and risk factors. Allergy Asthma Immunol Res (2011) 1.04
Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach. J Occup Med Toxicol (2012) 1.04
Environmental isocyanate-induced asthma: morphologic and pathogenetic aspects of an increasing occupational disease. Int J Environ Res Public Health (2011) 0.93
CTNNA3 (α-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population. Toxicol Sci (2012) 0.93
Biomarkers predicting isocyanate-induced asthma. Allergy Asthma Immunol Res (2010) 0.93
Agents, old and new, causing occupational asthma. Occup Environ Med (2001) 0.92
Pro/Con debate: Is occupational asthma induced by isocyanates an immunoglobulin E-mediated disease? Clin Exp Allergy (2010) 0.92
Gene-environment interactions in asthma. Occup Environ Med (2006) 0.91
Pathogenesis and disease mechanisms of occupational asthma. Immunol Allergy Clin North Am (2011) 0.90
Genetic susceptibility to occupational exposures. Occup Environ Med (2008) 0.87
Genetic variants in the major histocompatibility complex class I and class II genes are associated with diisocyanate-induced Asthma. J Occup Environ Med (2014) 0.79
Influence of polymorphic metabolic enzymes on biotransformation and effects of diphenylmethane diisocyanate. Int Arch Occup Environ Health (2007) 0.78
Genetic variability in susceptibility to occupational respiratory sensitization. J Allergy (Cairo) (2011) 0.78
Early incidence of occupational asthma among young bakers, pastry-makers and hairdressers: design of a retrospective cohort study. BMC Public Health (2010) 0.77
Gene-environment interaction from international cohorts: impact on development and evolution of occupational and environmental lung and airway disease. Semin Respir Crit Care Med (2015) 0.77
Probable role of Beta 2-adrenergic receptor gene haplotype in toluene diisocyanate-induced asthma. Allergy Asthma Immunol Res (2010) 0.76
Influence of genetic factors on toluene diisocyanate-related symptoms: evidence from a cross-sectional study. Environ Health (2008) 0.76
Association of HLA-DRB1 Gene Polymorphism with Risk of Asthma: A Meta-Analysis. Med Sci Monit Basic Res (2016) 0.76
Asthma Symptoms and Specific IgE Levels among Toluene Diisocyanate (TDI) Exposed Workers in Tehran, Iran. Iran J Public Health (2013) 0.75
Usefulness of Biomarkers in Work-Related Airway Disease. Curr Treat Options Allergy (2017) 0.75
Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood (2001) 3.84
Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 3.82
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 3.69
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax (1998) 3.07
Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med (1994) 3.06
Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol (1997) 2.81
A test of the nature of cosmic acceleration using galaxy redshift distortions. Nature (2008) 2.65
Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med (1998) 2.62
Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.58
Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J (2003) 2.57
Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax (1996) 2.52
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 2.52
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest (2001) 2.05
Fatal asthma attack during an inhalation challenge with ultrasonically nebulized distilled water. J Allergy Clin Immunol (1995) 2.04
Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis (1993) 2.02
Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history. Eur Respir J (2011) 1.99
Old galaxies in the young Universe. Nature (2004) 1.90
Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax (2004) 1.89
Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. Am J Respir Crit Care Med (2001) 1.88
Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis (1983) 1.85
Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. Eur Respir J (2003) 1.84
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med (1997) 1.79
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer. Eur Respir J (2007) 1.73
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy (1996) 1.72
P2 purinoceptors in the immune system. Ciba Found Symp (1996) 1.68
Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med (1995) 1.63
A profile of fertilization in mammals. Nat Cell Biol (2001) 1.63
Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax (2006) 1.60
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax (2004) 1.58
Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med (1995) 1.55
Low domestic exposure to house dust mite allergens (Der p 1) is associated with a reduced non-specific bronchial hyper-responsiveness in mite-sensitized asthmatic subjects under optimal drug treatment. Clin Exp Allergy (2001) 1.52
Cytolytic P2X purinoceptors. Cell Death Differ (1998) 1.50
Modification of the methacholine inhalation test and its epidemiologic use in polyurethane workers. Am Rev Respir Dis (1986) 1.49
Persistent asthma due to isocyanates. A follow-up study of subjects with occupational asthma due to toluene diisocyanate (TDI). Am Rev Respir Dis (1988) 1.48
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.44
Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. Eur Respir J (2007) 1.44
Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa. Am J Respir Crit Care Med (1996) 1.44
Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J (2010) 1.41
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med (2000) 1.40
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax (2008) 1.40
Venous blood platelets decrease during allergen-induced asthmatic reactions. Clin Exp Allergy (1990) 1.39
Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. Allergy (2007) 1.36
Increased activation of p38 MAPK in COPD. Eur Respir J (2007) 1.33
Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.29
Control of neurotransmission by prostaglandins in canine trachealis smooth muscle. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.27
Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax (2003) 1.26
Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways. Am J Respir Crit Care Med (2000) 1.24
Neutrophil depletion inhibits airway hyperresponsiveness induced by ozone exposure. Am Rev Respir Dis (1984) 1.23
Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med (1994) 1.20
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J (2004) 1.20
Interleukin-13 and -4 expression in the central airways of smokers with chronic bronchitis. Eur Respir J (2003) 1.20
Airway hyperresponsiveness and changes in cell counts in bronchoalveolar lavage after ozone exposure in dogs. Am Rev Respir Dis (1984) 1.18
Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am Rev Respir Dis (1987) 1.16
Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J Immunol (1999) 1.15
The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy (2009) 1.15
Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol (1999) 1.13
Occupational asthma due to isocyanates. Eur Respir J (1988) 1.13
Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur Respir J (2006) 1.13
Repeated tuberculin testing does not induce false positive ELISPOT results. Thorax (2006) 1.13
Conditional mutations in the yeast DNA primase genes affect different aspects of DNA metabolism and interactions in the DNA polymerase alpha-primase complex. Genetics (1993) 1.11
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells. Cytotherapy (2008) 1.11
Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease. Allergy (2009) 1.09
Predominant emphysema phenotype in chronic obstructive pulmonary. Eur Respir J (2003) 1.09
Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol (1992) 1.08
Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J (1993) 1.06
Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis (1991) 1.06
Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectives. Br J Ind Med (1993) 1.03
Increased expression of heme oxygenase (HO)-1 in alveolar spaces and HO-2 in alveolar walls of smokers. Am J Respir Crit Care Med (2001) 1.02
HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens (2008) 1.01
Indomethacin inhibits the airway hyperresponsiveness but not the neutrophil influx induced by ozone in dogs. Am Rev Respir Dis (1984) 1.00
Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med (1995) 1.00
Effect of oxidant air pollutants on the respiratory system: insights from experimental animal research. Eur Respir J (1995) 1.00
Symbols, abbreviations and units. Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Eur Respir J Suppl (1993) 1.00
Sputum eosinophilia after asthmatic responses induced by isocyanates in sensitized subjects. Clin Exp Allergy (1994) 0.99
Prednisone inhibits late asthmatic reactions and airway inflammation induced by toluene diisocyanate in sensitized subjects. J Allergy Clin Immunol (1987) 0.99
HLA class II alleles in isocyanate-induced asthma. Am J Respir Crit Care Med (1994) 0.99
Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod (2004) 0.99
Efficacy of standard rehabilitation in COPD outpatients with comorbidities. Eur Respir J (2010) 0.98
Corticosteroid inhibition of airway microvascular leakage. Am Rev Respir Dis (1991) 0.98
Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide. Am J Respir Crit Care Med (1999) 0.96
AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia. Oncogene (2012) 0.95
Lack of association of HLA class I genes and TNF alpha-308 polymorphism in toluene diisocyanate-induced asthma. Allergy (2004) 0.95
Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study. Allergy (2008) 0.95
Delivering effective asthma care--how do we implement asthma guidelines? Eur Respir J (2000) 0.95
Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma. Am Rev Respir Dis (1992) 0.95
The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region. FEBS Lett (2000) 0.94
Time course of the increase in airway responsiveness associated with late asthmatic reactions to toluene diisocyanate in sensitized subjects. J Allergy Clin Immunol (1985) 0.94
Mouse zona pellucida genes and glycoproteins. Cytogenet Genome Res (2004) 0.94
Regular vs prn nebulized treatment in wheeze preschool children. Allergy (2009) 0.93
Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis. Mult Scler (2006) 0.93
Integrin expression on neutrophils and mononuclear cells in blood and induced sputum in stable asthma. Allergy (1999) 0.93
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57. Eur Respir J (1996) 0.93
Bronchial smooth muscle responses evoked by toluene diisocyanate are inhibited by ruthenium red and by indomethacin. Eur J Pharmacol (1991) 0.92
Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics. Am J Respir Crit Care Med (1994) 0.92
Clusterin (CLU) and lung cancer. Adv Cancer Res (2009) 0.92
Macrolides for chronic asthma. Cochrane Database Syst Rev (2005) 0.92
Near-fatal asthma phenotype in the ENFUMOSA Cohort. Clin Exp Allergy (2007) 0.91